William Blair & Company’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-10,728
| Closed | -$175K | – | 2028 |
|
|
2021
Q4 | $175K | Sell |
10,728
-10,922
| -50% | -$178K | ﹤0.01% | 1608 |
|
|
2021
Q3 | $276K | Buy |
21,650
+10,900
| +101% | +$139K | ﹤0.01% | 1366 |
|
|
2021
Q2 | $152K | Sell |
10,750
-7,000
| -39% | -$99K | ﹤0.01% | 1558 |
|
|
2021
Q1 | $276K | Buy |
+17,750
| New | +$276K | ﹤0.01% | 1362 |
|
|
2018
Q4 | – | Sell |
-16,310
| Closed | -$599K | – | 1794 |
|
|
2018
Q3 | $599K | Sell |
16,310
-1,490
| -8% | -$54.7K | ﹤0.01% | 898 |
|
|
2018
Q2 | $623K | Sell |
17,800
-360
| -2% | -$12.6K | ﹤0.01% | 873 |
|
|
2018
Q1 | $844K | Sell |
18,160
-1,215
| -6% | -$56.5K | 0.01% | 755 |
|
|
2017
Q4 | $727K | Sell |
19,375
-24,831
| -56% | -$932K | ﹤0.01% | 842 |
|
|
2017
Q3 | $2.35M | Buy |
44,206
+1,487
| +3% | +$79.2K | 0.02% | 522 |
|
|
2017
Q2 | $2.44M | Buy |
42,719
+4,761
| +13% | +$271K | 0.02% | 524 |
|
|
2017
Q1 | $2.14M | Buy |
37,958
+147
| +0.4% | +$8.27K | 0.02% | 528 |
|
|
2016
Q4 | $2.16M | Buy |
37,811
+284
| +0.8% | +$16.2K | 0.02% | 481 |
|
|
2016
Q3 | $2.33M | Buy |
37,527
+9,321
| +33% | +$579K | 0.02% | 460 |
|
|
2016
Q2 | $1.6M | Sell |
28,206
-1,011
| -3% | -$57.2K | 0.01% | 514 |
|
|
2016
Q1 | $1.87M | Buy |
29,217
+2,829
| +11% | +$181K | 0.02% | 470 |
|
|
2015
Q4 | $3.71M | Buy |
26,388
+8,295
| +46% | +$1.17M | 0.03% | 341 |
|
|
2015
Q3 | $1.75M | Buy |
18,093
+2,335
| +15% | +$226K | 0.02% | 569 |
|
|
2015
Q2 | $2.39M | Buy |
+15,758
| New | +$2.39M | ﹤0.01% | 1283 |
|